Alpha Cognition Inc. (NASDAQ:ACOG) Sees Large Decline in Short Interest

Alpha Cognition Inc. (NASDAQ:ACOG) was the target of a significant drop in short interest in February. As of February 13th, there was short interest totaling 228,500 shares, a drop of 32.1% from the January 29th total of 336,614 shares. Based on an average daily trading volume, of 85,433 shares, the days-to-cover ratio is currently 2.7 days. Currently, 1.2% of the shares of the stock are sold short. Currently, 1.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 85,433 shares, the days-to-cover ratio is currently 2.7 days.

Alpha Cognition Stock Performance

Shares of Alpha Cognition stock opened at $6.00 on Friday. The business’s fifty day moving average price is $5.78 and its 200 day moving average price is $6.63. Alpha Cognition has a twelve month low of $3.75 and a twelve month high of $11.54. The stock has a market capitalization of $130.44 million, a P/E ratio of -4.38 and a beta of 2.60.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ACOG. HC Wainwright reissued a “buy” rating and set a $18.00 price objective on shares of Alpha Cognition in a research note on Friday, December 19th. Wall Street Zen upgraded shares of Alpha Cognition from a “sell” rating to a “hold” rating in a report on Saturday, November 15th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Alpha Cognition presently has a consensus rating of “Buy” and an average price target of $18.00.

Institutional Trading of Alpha Cognition

Institutional investors and hedge funds have recently bought and sold shares of the business. Green Alpha Advisors LLC purchased a new position in Alpha Cognition in the fourth quarter valued at approximately $72,000. Geode Capital Management LLC purchased a new position in shares of Alpha Cognition in the 2nd quarter valued at $112,000. Massar Capital Management LP purchased a new position in shares of Alpha Cognition in the 2nd quarter valued at $116,000. Berkshire Asset Management LLC PA lifted its holdings in shares of Alpha Cognition by 50.7% during the 3rd quarter. Berkshire Asset Management LLC PA now owns 17,824 shares of the company’s stock valued at $116,000 after acquiring an additional 6,000 shares in the last quarter. Finally, Zullo Investment Group Inc. purchased a new stake in Alpha Cognition during the 3rd quarter worth $127,000.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.